Ikena Oncology News

Wedbush: The Ikena Oncology (IKNA.US) rating was reaffirmed and adjusted from superior to superior market rating, with a target price of $8.00.

Zhitong FinanceMay 14 07:31

Ikena Oncology Analyst Ratings

BenzingaMay 14 07:27

Wedbush Reiterates Outperform on Ikena Oncology, Maintains $8 Price Target

BenzingaMay 14 07:29

Ikena Oncology (IKNA) Gets a Buy From Wedbush

TipRanksMay 14 06:55

Ikena Oncology Analyst Ratings

BenzingaMar 19 06:03

Ikena Oncology's Promising Drug Pipeline Merits a Buy Rating

TipRanksMar 12 17:05

Ikena Oncology Analyst Ratings

BenzingaMar 12 09:48

HC Wainwright & Co. Maintains Buy on Ikena Oncology, Maintains $11 Price Target

BenzingaMar 12 09:49

Ikena Oncology (IKNA) Gets a Buy From Wedbush

TipRanksJan 22 13:24

Buy Rating on Ikena Oncology: Undervalued Assets and Promising Pipeline in Oncology Sector

TipRanksJan 22 12:46

HC Wainwright & Co. Reiterates Buy on Ikena Oncology, Maintains $11 Price Target

BenzingaJan 19 06:16

Ikena Oncology Analyst Ratings

BenzingaJan 19 06:15

HC Wainwright Adjusts Ikena Oncology Price Target to $11 From $18, Maintains Buy Rating

MT NewswiresNov 10, 2023 07:13

Wedbush Lowers Ikena Oncology's Price Target to $8 From $11, Moves Estimates Launch Timings for IK-930; Maintains Outperform Rating

MT NewswiresNov 10, 2023 06:03

HC Wainwright & Co. Maintains Buy on Ikena Oncology, Lowers Price Target to $11

BenzingaNov 9, 2023 16:53

Ikena Oncology Analyst Ratings

BenzingaNov 9, 2023 16:51

Analysts Have Conflicting Sentiments on These Healthcare Companies: Adicet Bio (ACET), Biogen (BIIB) and Ikena Oncology (IKNA)

TipRanksNov 9, 2023 13:09

Positive Outlook for Ikena Oncology: Buy Rating Reiterated Amid Promising IK-930 Drug Developments

TipRanksNov 9, 2023 12:30

Wedbush Initiates Coverage On Ikena Oncology With Outperform Rating, Announces Price Target of $11

BenzingaSep 22, 2023 03:25

Ikena Oncology Analyst Ratings

BenzingaSep 22, 2023 03:23